BiotechTube
Home/PharmaEssentia/Cheng-Ku (Jack) Hwang
C(

Cheng-Ku (Jack) Hwang

General Manager, HQ

PharmaEssentia

Therapeutic Areas

Hematologic OncologyOncology

PharmaEssentia Pipeline

DrugIndicationPhase
Ropeginterferon alfa-2b (BESREMi®)Polycythemia Vera (PV)Approved
Ropeginterferon alfa-2bEssential Thrombocythemia (ET)Phase III
KX01 (Tirbanibulin)Gastric/Gastro-esophageal/Esophageal CancersPhase I

Leadership Team at PharmaEssentia

KL
Ko-Chung Lin
Founder and CEO
CT
Ching-Leou Teng
Chairperson
LL
Lih-Ling Lin
Chief Scientific Officer
AQ
Albert Qin
Chief Medical Officer
KY
Katsuya Yonezu
Representative Director & General Manager of Japan Operations
View full PharmaEssentia profile